Huang Zheng-jie, Feng Qing-zhao, You Jun, Xu Lin, Luo Wei-yuan, Yi Wen-cheng, Zeng Yue-yue, Luo Qi
Department of Surgical Oncology, First Affiliated Hospital, Xiamen University & Xiamen Cancer Center, Xiamen 361003, China.
Zhonghua Yi Xue Za Zhi. 2013 Jul 23;93(28):2235-40.
To explore the therapeutic efficacy of double suicide gene system driven by carcinoembryonic antigen (CEA) promoter (Cp-CDglyTK) on colorectal carcinoma xenograft in nude mice.
The plasmid pcDNA3.1(-)Cp-CDglyTK was transfected into the CEA-positive SW480 and CEA-negative HeLa cells respectively. The expression of suicide gene was detected by RT-PCR. And the transfected cells were treated with 5-fluorocytosine (5-FC) and ganciclovir (GCV) at different concentrations and the cell-killing and bystander effects assayed by methyl thiazolyl tetrazolium (MTT). By a transplantation of cultivated cells, SW480 or HeLa cell lines were injected subcutaneously into right axillary of nude mice to establish 96 SW480 and 72 HeLa tumor animal models. Nude mice were completely randomized with statistical software according to tumor volume. For prodrug therapy, 48 SW480-bearing mice were divided equally into 4 groups of I-IV. At the same time, 48 HeLa-bearing mice were divided equally into 4 groups of V-VIII. Groups I & V received an intratumoral injection of PBS, groups II & VIGCV and 5-FC intratumorally, groups III & VII PBS intraperitoneally and groups IV & VIII GCV and 5-FC intraperitoneally. Forty-eight SW480-bearing mice were divided equally into 4 groups of IX∼XII and 24 Hela-bearing ones into groups of & in therapy experiment by suicide gene plus prodrug. Six groups received an intratumoral injection of liposome Lipofectamine and plasmid CP-CDglyTK and then an intraperitoneal injection of drug. The groups of IX and received an injection of PBS, group X GCV, group XI 5-FC and groups XII & GCV and 5-FC. The observation parameters included tumor bulk, tumor weight, survival time and treatment effect in each group.
SW480 cells transfected by plasmid pcDNA3.1(-)Cp- CDglyTK expressed CDglyTK gene. The inhibition rates of GCV and 5-FC were significantly higher than those of HeLa cells (59.87% ± 0.21% vs 9.90% ± 0.09%, P < 0.01). And higher inhibition rates and stronger bystander effect existed in double versus single produg (all P < 0.05). Tumor size, final tumor weight and survival time of nude mice in groups ofII, IV, VI & VIII had no significant difference with groups ofI, III, V & VII (all P < 0.05). Final tumor size and weight of group XII was significantly smaller than those of groups of IX, X and XI ((150.0 ± 3.2) vs (522.5 ± 1.9) and (256.8 ± 10.4) and (260.7 ± 2.2) mm(3), (54.1 ± 10.4) vs (682.0 ± 12.0) and (251.8 ± 15.1) and (271.6 ± 17.7) mg, all P < 0.05). Meanwhile, the tumor inhibition rate and survival time of group XII(92.1% and (25.7 ± 0.8)d) were significant higher and longer than group X (63.1% and (21.8 ± 0.5) d) and group XI (60.2% and (18.0 ± 0.9) d) (all P < 0.05). However, no significant difference existed in tumor size, final tumor weight and survival time between groups and (all P > 0.05). The inhibition rate of group was merely 0.9%.
CDglyTK double suicide gene system driven by CEA promoter may inhibit CEA positive colorectal cancer xenograft in prodrug-treated nude mice.
探讨癌胚抗原(CEA)启动子驱动的双自杀基因系统(Cp-CDglyTK)对裸鼠结直肠癌移植瘤的治疗效果。
将质粒pcDNA3.1(-)Cp-CDglyTK分别转染至CEA阳性的SW480细胞和CEA阴性的HeLa细胞。采用逆转录-聚合酶链反应(RT-PCR)检测自杀基因的表达。将转染后的细胞用不同浓度的5-氟胞嘧啶(5-FC)和更昔洛韦(GCV)处理,通过甲基噻唑基四氮唑(MTT)法检测细胞杀伤及旁观者效应。通过培养细胞移植,将SW480或HeLa细胞系皮下注射到裸鼠右腋窝,建立96只SW480和72只HeLa肿瘤动物模型。使用统计软件根据肿瘤体积将裸鼠完全随机分组。对于前体药物治疗,将48只荷SW480小鼠平均分为I-IV组。同时,将48只荷HeLa小鼠平均分为V-VIII组。I组和V组瘤内注射磷酸盐缓冲液(PBS),II组和VI组瘤内注射GCV和5-FC,III组和VII组腹腔注射PBS,IV组和VIII组腹腔注射GCV和5-FC。48只荷SW480小鼠平均分为IX∼XII组,24只荷HeLa小鼠分为XIII和XIV组,进行自杀基因加前体药物治疗实验。六组均瘤内注射脂质体Lipofectamine和质粒CP-CDglyTK,然后腹腔注射药物。IX组和XIII组注射PBS,X组注射GCV,XI组注射5-FC,XII组和XIV组注射GCV和5-FC。观察指标包括每组的肿瘤体积、肿瘤重量、生存时间及治疗效果。
质粒pcDNA3.1(-)Cp-CDglyTK转染的SW480细胞表达CDglyTK基因。GCV和5-FC对其抑制率显著高于HeLa细胞(59.87%±0.21%对9.90%±0.09%,P<0.01)。双前体药物组的抑制率更高,旁观者效应更强(均P<0.05)。II、IV、VI和VIII组裸鼠的肿瘤大小、最终肿瘤重量和生存时间与I、III、V和VII组相比无显著差异(均P<0.05)。XII组的最终肿瘤大小和重量显著小于IX、X和XI组((150.0±3.2)对(522.5±1.9)、(256.8±10.4)和(260.7±2.2)mm³,(54.1±10.4)对(682.0±12.0)、(251.8±15.1)和(271.6±17.7)mg,均P<0.05)。同时,XII组的肿瘤抑制率(92.1%)和生存时间((25.7±0.8)天)显著高于X组(63.1%和(21.8±0.5)天)和XI组(60.2%和(18.0±0.9)天)(均P<0.05)。然而,XIII组和XIV组之间的肿瘤大小、最终肿瘤重量和生存时间无显著差异(均P>0.05)。XIII组的抑制率仅为0.9%。
CEA启动子驱动的CDglyTK双自杀基因系统可抑制前体药物处理的裸鼠体内CEA阳性结直肠癌移植瘤。